The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Estrogen for Alzheimer’s disease in women: Randomized, double-blind, placebo-controlled trial
Abstract
BACKGROUND: AD, the most prevalent cause of dementia, affects twice as many women as men. Therapeutic options are limited, but results of prior studies support the hypothesis that estrogen treatment may improve symptoms of women with this disorder. METHODS: Forty-two women with mild-to-moderate dementia due to AD were enrolled into a randomized, double-blind, placebo-controlled, parallel-group trial of unopposed conjugated equine estrogens (1.25 mg/day) for 16 weeks. RESULTS: Outcome data were available for 40 women at 4 weeks and 36 women at 16 weeks. At both 4 and 16 weeks, there were no significant differences or statistical trends between treatment groups on the primary outcome measure (the cognitive subscale of the Alzheimer's Disease Assessment Scale), clinician-rated global impression of change, or caregiver-rated functional status. Exploratory analyses of mood and specific aspects of cognitive performance also failed to demonstrate substantial group differences. CONCLUSION: Although conclusions are limited by small sample size and the possibility of a type II error, results suggest that short-term estrogen therapy does not improve symptoms of most women with AD. These findings do not address possible long-term effects of estrogen in AD, possible interactions between estrogen and other treatment modalities, or putative effects of estrogen in preventing or delaying onset of this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living
Lawton, M. P., & Brody, E. M. (1969) · The Gerontologist · doi:10.1093/geront/9.3_part_1.179 · Cited by 18,540
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Comparative distribution of estrogen receptor-? and -? mRNA in the rat central nervous system
Shughrue, P. J., Lane, M. V., & Merchenthaler, I. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971201)388:4<507::aid-cne1>3.0.co;2-6 · Cited by 2,259
Brookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., & Mayeux, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03356-9 · Cited by 1,647
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T., & Donepezil Study Group* (1998) · Neurology · doi:10.1212/wnl.50.1.136 · Cited by 1,618
Self-citationPathological verification of ischemic score in differentiation of dementias
Rosen, W. G., Terry, R. D., Fuld, P. A., Katzman, R., & Peck, A. (1980) · Annals of Neurology · doi:10.1002/ana.410070516 · Cited by 1,273
Knapp, M. J. (1994) · JAMA · doi:10.1001/jama.271.13.985 · Cited by 1,004
Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Lingle, D. D., & Metter, E. (1997) · Neurology · doi:10.1212/wnl.48.6.1517 · Cited by 966
Rosler, M., Anand, R., Cicin-Sain, A., Gauthier, S., Agid, Y., Dal-Bianco, P., Stahelin, H. B., Hartman, R., Gharabawi, M., & Bayer, T. (1999) · BMJ · doi:10.1136/bmj.318.7184.633 · Cited by 943
Effects of estrogen on memory function in surgically menopausal women
Phillips, S. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90007-t · Cited by 741
Schneider, L. S., Olin, J. T., Doody, R. S., Clark, C. M., Morris, J. C., Reisberg, B., Schmitt, F. A., Grundman, M., Thomas, R. G., & Ferris, S. H. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00004 · Cited by 647
Henderson, V. W. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210068014 · Cited by 590
Self-citationEstrogen reduces neuronal generation of Alzheimer β-amyloid peptides
Xu, H., Gouras, G. K., Greenfield, J. P., Vincent, B., Naslund, J., Mazzarelli, L., Fried, G., Jovanovic, J. N., Seeger, M., Relkin, N. R., et al. (1998) · Nature Medicine · doi:10.1038/nm0498-447 · Cited by 560
Estrogen Replacement Therapy and Risk of Alzheimer Disease
Paganini‐Hill, A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.19.2213 · Cited by 524
Self-citation(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.390 · Cited by 408
Pike, C. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721552.x · Cited by 387
Estimated Prevalence of Alzheimer's Disease in the United States
Evans, D. A. (1990) · The Milbank Quarterly · doi:10.2307/3350099 · Cited by 357
Comparison of pharmacodynamic properties of various estrogen formulations
Mashchak, C. A., Lobo, R. A., Dozono-Takano, R., Eggena, P., Nakamura, R. M., Brenner, P. F., & Mishell, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90218-6 · Cited by 316
Postmenopausal estrogen replacement therapy and risk of AD: A population-based study
Waring, S. C., Rocca, W. A., Petersen, R. C., O’Brien, P. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.5.965 · Cited by 293
Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging
Baldereschi, M., Di Carlo, A., Lepore, V., Bracco, L., Maggi, S., Grigoletto, F., Scarlato, G., Amaducci, L., & ILSA Working Group* (1998) · Neurology · doi:10.1212/wnl.50.4.996 · Cited by 257
Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease
Schneider, L. S., Farlow, M. R., Henderson, V. W., & Pogoda, J. M. (1996) · Neurology · doi:10.1212/wnl.46.6.1580 · Cited by 250
Self-citationAsthana, S., Craft, S., Baker, L. D., Raskind, M. A., Birnbaum, R. S., Lofgreen, C. P., Veith, R. C., & Plymate, S. R. (1999) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00020-7 · Cited by 240
Stone, D. J., Rozovsky, I., Morgan, T. E., Anderson, C. P., & Finch, C. E. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03180.1998 · Cited by 237
Allocation of patients to treatment groups in a controlled clinical study
White, S. J., & Freedman, L. S. (1978) · British Journal of Cancer · doi:10.1038/bjc.1978.124 · Cited by 191
Cognitive skills associated with estrogen replacement in women with Alzheimer's disease
Henderson, V. W., Watt, L., & Galen Buckwalter, J. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00060-7 · Cited by 189
Self-citationDeterminants of Compliance with Anticoagulation: A Case-Control Study
Arnsten, J. H., Gelfand, J. M., & Singer, D. E. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)90048-6 · Cited by 188
Doraiswamy, P. M., Bieber, F., Kaiser, L., Krishnan, K. R., Reuning-Scherer, J., & Gulanski, B. (1997) · Neurology · doi:10.1212/wnl.48.6.1511 · Cited by 165
The Physiology and Pharmacology of Melatonin in Humans
Geoffriau, M., Brun, J., Chazot, G., & Claustrat, B. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023160 · Cited by 164
Nongenomic Actions of Estrogen in the Brain: Physiological Significance and Cellular Mechanisms
Wong, M., Thompson, T. L., & Moss, R. L. (1996) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v10.i2.30 · Cited by 127
Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report.
Kramer‐Ginsberg, E., Mohs, R. C., Aryan, M., Lobel, D., Silverman, J. M., Davidson, M., & Davis, K. L. (1988) · PubMed · Cited by 83
Estrogens in the Pathogenesis and Treatment of Alzheimer's Disease in Postmenopausal Women
Fillit, H. M. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb55795.x · Cited by 79
Estrogen Replacement Therapy for the Prevention and Treatment of Alzheimer??s Disease
Henderson, V. W. (1997) · CNS Drugs · doi:10.2165/00023210-199708050-00001 · Cited by 49
Self-citationA Collateral Source Version of the Geriatric Depression Rating Scale
Nitcher, R. L., Burke, W. J., Roccaforte, W. H., & Wengel, S. P. (1993) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199300120-00007 · Cited by 45
Troy, S. M., HICKS, D. R., Parker, V. D., Jusko, W. J., Rofsky, H. E., & Porter, R. J. (1994) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80521-1 · Cited by 19
Cited by
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Doody, R. S., Stevens, J. C., Beck, C., Dubinsky, R. M., Kaye, J. A., Gwyther, L., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,720
Physical activity and risk of cognitive impairment and dementia in elderly persons
Laurin, D., Verreault, R., Lindsay, J., MacPherson, K., & Rockwood, K. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.498 · Cited by 1,561
Cummings, J. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040223 · Cited by 1,152
Metadata
- Authors
- Henderson, V. W., Paganini-Hill, A., Miller, B. L., Elble, R. J., Reyes, P. F., Shoupe, D., McCleary, C. A., Klein, R. A., Hake, A. M., & Farlow, M. R.
- Venue
- Neurology
- Published
- 2000-01-25
- Volume
- 54
- Issue
- 2
- Pages
- 295-295
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2128007559
- Cited by
- 550
- References
- 38
- FWCI
- 54.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.